NanoGroup S.A.
WSE: NNG.WA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Warsaw Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Przemyslaw Daniel Mazurek
- Employees
- 46
- Headquarters
- Warsaw, Poland
- IPO year
- 2018
- Market cap
- PLN 79.9M
- Website
- https://nanogroup.eu
Loading NNG…
Loading profile data…Frequently asked questions about NNG
What does NanoGroup S.A. (NNG.WA) do?
NanoGroup S.A. operates as a biotechnology company. It develops and licenses early-stage biotechnology and medical projects in the areas of oncology, transplantology, and blood donations to international biotech companies and pharmaceutical companies. NanoGroup S.A was incorporated in 2016 and is based in Warsaw, Poland.
Where does NNG.WA trade?
NanoGroup S.A. (NNG.WA) trades on the Warsaw Stock Exchange.
What sector is NNG.WA in?
NanoGroup S.A. (NNG.WA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of NanoGroup S.A.?
Przemyslaw Daniel Mazurek is the chief executive officer of NanoGroup S.A. (NNG.WA).
Where is NanoGroup S.A. headquartered?
NanoGroup S.A. is headquartered in Poland.
Does NNG.WA pay a dividend?
NanoGroup S.A. (NNG.WA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NNG.WA go public?
NanoGroup S.A. (NNG.WA) completed its initial public offering in 2018.